On September 30, according to the latest equity disclosure data from the Hong Kong Stock Exchange, on September 24, 2024, Sinopharm (01099.HK) was reduced by FMR LLC to an average price of 17.1139 Hong Kong dollars per share, reducing 11.5636 million shares, involving approximately 0.198 billion Hong Kong dollars.

After the reduction, FMR LLC's latest number of shares held is 150,406,749 shares, and the shareholding ratio has decreased from 12.07% to 11.21%.